• Athersys Inc., of Cleveland, said it received a Small Business Innovation Research Fast Track grant from the National Heart, Lung, and Blood Institute, which will support a Phase II study evaluating Multistem therapy in patients who have suffered heart attacks, or acute myocardial infarctions.